Mofilet S 360 Mg Tablet

About Mofilet S 360 Mg Tablet

Mofilet S 360 mg tablet contains mycophenolate mofetil as its active ingredient, which is an immunosuppressant medication primarily used to prevent organ rejection following kidney, heart, or liver transplants. It is also prescribed for certain autoimmune conditions such as lupus nephritis (lupus affecting the kidneys) and other conditions where the immune system attacks the bodys own tissues.

Mycophenolate mofetil works by suppressing the immune system. It inhibits the proliferation of immune cells (specifically T and B lymphocytes), which are responsible for the rejection of transplanted organs and the inflammation seen in autoimmune diseases. By suppressing these immune cells, Mofilet S helps prevent organ rejection and reduces the activity of autoimmune diseases.

The typical dosage for Mofilet S varies depending on the condition being treated and the patients medical history. It is usually taken orally, in tablet form, once or twice a day, with or without food. The exact dosage will be tailored by a healthcare provider based on factors such as the patient's body weight, organ type, and response to treatment.

As with any immunosuppressant medication, Mofilet S comes with a risk of side effects. Common side effects include gastrointestinal issues like nausea, diarrhea, and vomiting. Long-term use of mycophenolate mofetil can also increase the risk of infections, as it suppresses the immune system, making the body more vulnerable to bacterial, viral, and fungal infections. It may also increase the risk of certain cancers, particularly lymphoma, over time. Regular check-ups and blood tests are important for monitoring the patient's health during treatment.

Patients who are pregnant or planning to become pregnant should avoid using Mofilet S, as it can cause birth defects. Proper contraception is advised for both men and women during treatment and for some time after stopping the medication.

Enteric-Coated Immunosuppressant for Transplant Care

Mofilet-S 360 Mg Tablet features an advanced enteric coating, safeguarding the Mycophenolate Sodium from stomach acid and ensuring targeted intestinal release. This formulation supports enhanced bioavailability and consistent therapeutic action, critical for organ transplant patients relying on effective immune suppression. Supplied in user-friendly 10-tablet strips, Mofilet-S 360 is distinguished by its reliability and proven performance in post-surgical transplant care.


Precise Pharmaceutical Standards and Safe Oral Dosage

Each Mofilet-S 360 Mg Tablet meets rigorous pharmaceutical standards, guaranteeing dosage accuracy and uncompromised safety. Developed and manufactured in India, these prescription-only tablets are managed by exporters, manufacturers, suppliers, and wholesalers, ensuring each tablet upholds optimal efficacy. The convenient oral form streamlines administration, with dosage frequency and duration determined by a healthcare professional according to the patient's clinical needs.


Proper Storage and Handling for Best Results

For optimal stability and effectiveness, Mofilet-S 360 Mg Tablets should be stored below 30C, away from direct sunlight and moisture. Correct storage preserves the tablet's enteric coating and potency over its 24-month shelf life. The portable strip packaging ensures ease of use for patients, both in clinical and home settings, supporting consistent medication adherence under a physician's guidance.